Area of research
Rheumatology · Dermatology
Research interest
Research interests include Urticaria and Related Conditions, Dermatology and Skin Diseases, Mast cells and histamine, and Coagulation, Bradykinin, Polyphosphates, and Angioedema.
Comment on ‘Patients with acute and chronic spontaneous urticaria have similar autoantibody profiles: CHAPEAU pilot study’: reply from authors
Remibrutinib in Chronic Spontaneous Urticaria
Update on the Treatment of Chronic Spontaneous Urticaria
Anti‐ <scp>KIT</scp> Barzolvolimab for Chronic Spontaneous Urticaria
Unmet needs in hereditary angioedema: an international survey of physicians
Remibrutinib in chronic spontaneous urticaria: 52-week results from two phase 3 studies
Sex matters in <scp>CSU</scp> : Women face greater burden and poorer urticaria control, especially in midlife— <scp>CURE</scp> insights
No allergy, but mast cells are involved: <scp>MRGPRX2</scp> in chronic inflammatory skin diseases
Evaluation of routine care of prurigo nodularis in Germany: retrospective chart review study (ADVANCE PN)
Safety and efficacy of barzolvolimab, an anti–KIT monoclonal antibody, in adults with moderate-to-severe prurigo nodularis: A randomized phase 1b intravenous single dose study
Nemolizumab in prurigo nodularis up to 100 weeks: <scp>OLYMPIA LTE</scp> interim analysis
Patients with acute and chronic spontaneous urticaria have similar autoantibody profiles: CHAPEAU pilot study
Improvement of Prurigo Nodularis With Erenumab
Validation of the Urticaria Activity Score for Cold Urticaria
Key Predictors of Adherence to a Mobile Health App for Managing Chronic Spontaneous Urticaria
Can Synthetic Data Allow for Smaller Sample Sizes in Chronic Urticaria Research?
The Prurigo Control Test reflects the severity of itch and skin lesions in patients with chronic prurigo: Data from a real‐world study
62278 Effect of Remibrutinib on Sleep and Daily Activities in Patients With Chronic Spontaneous Urticaria (CSU) up to Week 52 in the REMIX-1/-2 studies
The Role of Mast Cells in the Pathophysiology of Chronic Prurigo
Chronic Spontaneous Urticaria
Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonists
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis
Disease modification in chronic spontaneous urticaria
CRUSE<sup>®</sup>—An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria
Cutaneous Components Leading to Pruritus, Pain, and Neurosensitivity in Atopic Dermatitis: A Narrative Review
Mortality in adult patients with chronic spontaneous urticaria: A real-world cohort study
EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions
An emerging aeroallergen in Europe: Tree-of-Heaven (Ailanthus altissima [Mill.] Swingle) inventory and pollen concentrations – Taking a metropolitan region in Germany as an example
Development and Validation of a Patient-Reported Outcome Measure to Assess Disease Control in Chronic Prurigo
Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A <scp>CRUSE</scp> ® mobile health study